McIntosh, K. Community-acquired pneumonia in children. New England Journal of Medicine
2002; 346: 429–437.
Grijalva, CG, et al.
Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet
2007; 369: 1179–1186.
De, Wals P, et al.
Pneumonia after implementation of the pneumococcal conjugate vaccine program in the province of Quebec, Canada. Pediatric Infectious Disease Journal
2008; 27: 963–968.
Hortal, M, et al.
Hospitalized children with pneumonia in Uruguay: pre and post introduction of 7- and 13-valent pneumococcal conjugated vaccines into the National Immunization Program. Vaccine
2012; 30: 4934–4938.
Poehling, KA, et al.
Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. Journal of the American Medical Association
2006; 295: 1668–1674.
Esposito, S, et al.
Bacteremic pneumococcal community-acquired pneumonia in children less than 5 years of age in Italy. Pediatric Infectious Disease Journal
2012; 31: 705–710.
Chappuy, H, et al.
Nasopharyngeal carriage of individual Streptococcus pneumoniae serotypes during pediatric radiologically confirmed community acquired pneumonia following PCV7 introduction in Switzerland. BMC Infectious Diseases
2013; 13: 357.
Whitney, CG, et al.
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. New England Journal of Medicine
2003; 348: 1737–1746.
Hickey, RW, Bowman, MJ, Smith, GA. Utility of blood cultures in pediatric patients found to have pneumonia in the emergency department. Annals of Emergency Medicine
1996; 27: 721–725.
Cao, LD, et al.
Value of washed sputum gram stain smear and culture for management of lower respiratory tract infections in children. Journal of Infection and Chemotherapy
2004; 10: 31–36.
Uehara, S, et al.
Japanese guidelines for the management of respiratory infectious diseases in children 2007 with focus on pneumonia. Pediatrics International
2011; 53: 264–276.
Ishiwada, N, et al.
The incidence of pediatric invasive Haemophilus influenzae and pneumococcal disease in Chiba prefecture, Japan before and after the introduction of conjugate vaccines. Vaccine
2014; 32: 5425–5431.
Tanaka, J, et al.
Incidence of childhood pneumonia and serotype and sequence-type distribution in Streptococcus pneumoniae isolates in Japan. Epidemiology and Infection
2012; 140: 1111–1121.
Woodward, M. Epidemiology: Study Design and Data Analysis, 3rd edn.
Boca Raton: Chapman and Hall/CRC Press, 2013, pp. 9–10.
Enright, MC, Spratt, BG. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology
1998; 144: 3049–3060.
Heinze, G, Schemper, M. A solution to the problem of separation in logistic regression. Statistics in Medicine
2002; 21: 2409–2419.
Scott, JR, et al.
Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communities. Journal of Infectious Diseases
2012; 205: 280–288.
Griffin, MR, Grijalva, CG. Hospitalizations after a decade of pneumococcal vaccination. New England Journal of Medicine
2013; 369: 1662–1663.
Madhi, SA, et al.
The burden of childhood pneumonia in the developed world: a review of the literature. Pediatric Infectious Disease Journal
2013; 32: e119–127.
Kaplan, SL, et al.
Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine. Pediatric Infectious Disease Journal
2013; 32: 203–207.
Elemraid, MA, et al.
Impact of the 7-valent pneumococcal conjugate vaccine on the incidence of childhood pneumonia. Epidemiology and Infection
2013; 141: 1697–1704.
Pilishvili, T, et al.
Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. Journal of Infectious Diseases
2010; 201: 32–41.
Brueggemann, AB, et al.
Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. Journal of Infectious Diseases
2003; 187: 1424–1432.
Oikawa, J, et al.
Changes in nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis among healthy children attending a day-care centre before and after official financial support for the 7-valent pneumococcal conjugate vaccine and H. influenzae type b vaccine in Japan. Journal of Infection and Chemotherapy
2014; 20: 146–149.
Park, SY, et al.
Invasive pneumococcal infections among vaccinated children in the United States. Journal of Pediatrics
2010; 156: 478–483. e472.
Millar, EV, et al.
Pre- and post-conjugate vaccine epidemiology of pneumococcal serotype 6C invasive disease and carriage within Navajo and White Mountain Apache communities. Clinical Infectious Diseases
2010; 51: 1258–1265.
Steens, A, et al.
Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Vaccine
2013; 31: 6232–6238.
Ricketson, LJ, et al.
Trends in asymptomatic nasopharyngeal colonization with Streptococcus pneumoniae after introduction of the 13-valent pneumococcal conjugate vaccine in Calgary, Canada. Pediatric Infectious Disease Journal
2014; 33: 724–730.
Hackel, M, et al.
Serotype prevalence and antibiotic resistance in Streptococcus pneumoniae clinical isolates among global populations. Vaccine
2013; 31: 4881–4887.
Stephens, DS, et al.
Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment. Lancet
2005; 365: 855–863.
Hyde, TB, et al.
Macrolide resistance among invasive Streptococcus pneumoniae isolates. Journal of the American Medical Association
2001; 286: 1857–1862.
Sugiura, H, et al.
Prescription surveillance and polymerase chain reaction testing to identify pathogens during outbreaks of infection. BioMed Research International
2013; 2013: 746053.
Kohno, S. Clinical assessment of tosufloxacin tosilate. Journal of Infection and Chemotherapy
2002; 8: 19–27.
Vanderkooi, OG, et al.
Predicting antimicrobial resistance in invasive pneumococcal infections. Clinical Infectious Diseases
2005; 40: 1288–1297.
Kang, CI, et al.
Association of levofloxacin resistance with mortality in adult patients with invasive pneumococcal diseases: a post hoc analysis of a prospective cohort. Infection
2013; 41: 151–157.
Okada, T, et al.
Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. Clinical Infectious Diseases
2012; 55: 1642–1649.
Cherian, T, et al.
Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bulletin of the World Health Organization
2005; 83: 353–359.
Dagan, R, et al.
Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial. Clinical Infectious Diseases
2013; 57: 952–962.